Author:
Bauters Tiene,Dadkhah Adrin
Abstract
AbstractPatients undergoing HCT receive polymedication which carries the potential to result in drug interactions. To avoid unexpected outcomes, attention to drug interactions is crucial, especially when drugs with a narrow therapeutic index or inherent toxicity profile are involved.
Publisher
Springer International Publishing
Reference21 articles.
1. Ahmed S, Zhou Z, Zhou J, Chen SQ. Pharmacogenomics of drug metabolizing enzymes and transporters: relevance to precision medicine. Genomics Proteomics Bioinformatics. 2016;14:298–313.
2. Clinical pharmacology powered by ClinicalKey. Tampa: Elsevier. http://www.clinicalkey.com. Accessed 28 March 2023.
3. Enioutina EY, Salis ER, Job KM, Gubarev MI, Krepkova LV, Sherwin CM. Herbal medicines: challenges in the modern world. Part 5. Status and current directions of complementary and alternative herbal medicine worldwide. Expert Rev Clin Pharmacol. 2017;10:327–38.
4. Essmann S, Dadkhah A, Janson D, Wolschke C, Ayuk F, Kroger NM. Iron Chelation with Deferasirox increases Busulfan AUC during conditioning chemotherapy prior to allogeneic stem cell transplantation. Transplant Cell Ther. 2021:S2666636721013646.
5. Ferri N, Bellosta S, Baldessin L, Boccia D, Racagni G, Corsini A. Pharmacokinetics interactions of monoclonal antibodies. Pharmacol Res. 2016;111:592–9.